Fakultna Nemocnica S Poliklinikou Zilina

Clinical trials in ophthalmology focus mainly on diabetic macular edema, neovascular age-related macular degeneration, and geographic atrophy. The research is aimed at comparing new eye therapies with established treatments and improving long-term visual outcomes for people with retinal disease.

• Testing new and biosimilar treatments for diabetic macular edema and wet AMD
• Evaluating treatment effectiveness for neovascular age-related macular degeneration
• Studying options that may reduce injection burden while preserving vision

This work reflects a strong local focus on retinal disease care, with several studies comparing emerging therapies to widely used eye treatments.

The site is also active in neurology, with studies centered on acute ischemic stroke, high-risk transient ischemic attack, and multiple sclerosis. These trials are designed to improve prevention, assess long-term safety, and support better management of serious neurological conditions.

• Preventing recurrent events after stroke or transient ischemic attack
• Monitoring long-term safety in multiple sclerosis
• Supporting better treatment strategies for vascular and immune-related brain disease

The Neurology Department contributes to research that may help refine care for patients at risk of disability from cerebrovascular and chronic neurological disorders.

Cancer-related trials at the hospital include breast cancer, prostate cancer, and non-small cell lung cancer. The main purpose is to evaluate new treatment options, compare them with current standards, and gather additional safety and effectiveness information for people with advanced disease.

• Assessing new combinations for hormone receptor-positive, HER2-negative breast cancer
• Collecting long-term data in prostate cancer
• Comparing cancer therapies for advanced lung cancer

These studies show an interest in both targeted oncology and follow-up research that supports ongoing treatment decisions in advanced malignancies.

Research in this area includes trials for diabetic foot infections, where investigators are evaluating whether newer antibiotics can improve clinical response and safety compared with established therapy. The goal is to strengthen treatment options for infections that are often difficult to manage in patients with diabetes.

• Testing new antibacterial treatment approaches for diabetic foot infections
• Comparing clinical response and tolerability with standard care
• Supporting better infection control in complex diabetic wounds

This infection-focused work adds an important anti-infective dimension to the site’s broader clinical trial portfolio.

Trials in cardiovascular medicine are centered on reducing the risk of ischemic stroke after a major warning event. The research is designed to test whether newer preventive therapies can lower future vascular complications compared with placebo or standard care.

• Preventing recurrent stroke in high-risk patients
• Evaluating therapies aimed at lowering thrombotic risk
• Improving secondary prevention after cerebrovascular events

At Fakultna Nemocnica S Poliklinikou Zilina, this area connects closely with the hospital’s neurological expertise and its interest in vascular health.

The site’s trial activity also touches on musculoskeletal disease, mainly through studies linked to diabetic complications that affect mobility and daily function. The overall aim is to improve treatment effectiveness and support better recovery in patients with complex chronic illness.

• Addressing complications that can affect movement and wound healing
• Supporting better outcomes in diabetes-related conditions
• Exploring therapies that may improve quality of life

Although smaller in scope, this research area adds to the site’s broad clinical focus across chronic disease management.